SonoThera raised $125 million in Series B funding to advance ultrasound-mediated genetic medicines.
- Amount
- $125M
- Stage
- Series B
- Announced
- 10 June 2026
- Lead
- Vida Ventures
- Other investors
- ARK Invest, CureDuchenne Ventures, Leaps by Bayer, Otsuka Pharmaceutical, SymBiosis, UCB Ventures SA, Vivo Capital, ARCH Venture Partners, Alexandria Venture Investments, Duquesne Family Office, Illumina Ventures
- Use of funds
- Advance lead DMD and ADPKD programs into the clinic and expand pipeline across multiple organ systems.
- Checked
- Amount and date checked against the press source